Ozdemir F - Search Results

1

Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer.

Fidan E, Kavgaci H, Orem A, Yilmaz M, Yildiz B, Fidan S, Akcan B, Ozdemir F, Aydin F. Fidan E, et al. Among authors: ozdemir f. Tumour Biol. 2012 Oct;33(5):1519-25. doi: 10.1007/s13277-012-0403-6. Epub 2012 Apr 27. Tumour Biol. 2012. PMID: 22535370

2

Does nimesulide induce gastric mucosal damage? "A double-blind randomized placebo-controlled trial".

Kapicioglu S, Baki AH, Sari M, Ozdemir F, Kavgaci H. Kapicioglu S, et al. Among authors: ozdemir f. Hepatogastroenterology. 2000 Jul-Aug;47(34):1183-5. Hepatogastroenterology. 2000. PMID: 11020910 Clinical Trial.

3

Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.

Yavuz AA, Aydin F, Yavuz MN, Ilis E, Ozdemir F. Yavuz AA, et al. Among authors: ozdemir f. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):974-81. doi: 10.1016/s0360-3016(01)01737-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11704320 Clinical Trial.

4

The effects of losartan and fosinopril in hypertensive type 2 diabetic patients.

Kavgaci H, Sahin A, Onder Ersoz H, Erem C, Ozdemir F. Kavgaci H, et al. Among authors: ozdemir f. Diabetes Res Clin Pract. 2002 Oct;58(1):19-25. doi: 10.1016/s0168-8227(02)00102-x. Diabetes Res Clin Pract. 2002. PMID: 12161053 Clinical Trial.

5

Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma.

Aydin F, Yilmaz M, Ozdemir F, Kavgaci H, Yavuz MN, Yavuz AA. Aydin F, et al. Among authors: ozdemir f. Am J Clin Oncol. 2002 Dec;25(6):570-2. doi: 10.1097/00000421-200212000-00007. Am J Clin Oncol. 2002. PMID: 12478000

6

Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.

Kavgaci H, Ozdemir F, Aydin F, Yavuz A, Yavuz M. Kavgaci H, et al. Among authors: ozdemir f. J Exp Clin Cancer Res. 2002 Dec;21(4):475-9. J Exp Clin Cancer Res. 2002. PMID: 12636092

7

The effects of Medroxyprogesterone acetate on apoptosis of CD34+ cells.

Aydin F, Ozdemir F, Kavgaci H, Yilmaz M, Karti S. Aydin F, et al. Among authors: ozdemir f. Chemotherapy. 2003 May;49(1-2):66-70. doi: 10.1159/000069783. Chemotherapy. 2003. PMID: 12714814

8

The effects of dexamethasone on leukemic cells derived from patients with AML.

Ovali E, Ozdemir F, Aydin F, Kavgaci H, Tekelioglu Y, Büyükcelik A, Yilmaz M. Ovali E, et al. Among authors: ozdemir f. J Exp Clin Cancer Res. 2003 Mar;22(1):85-9. J Exp Clin Cancer Res. 2003. PMID: 12725327

9

Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin.

Karti SS, Ovali E, Ozgur O, Yilmaz M, Sonmez M, Ratip S, Ozdemir F. Karti SS, et al. Among authors: ozdemir f. Hepatogastroenterology. 2003 Nov-Dec;50(54):1864-6. Hepatogastroenterology. 2003. PMID: 14696420

10

The in-vitro effects of medroxyprogesterone acetate on acidic pH induced apoptosis of periferal blood mononuclear cells.

Ozdemir F, Ovali E, Aydin F, Kavgaci H, Büyükcelik A, Ucar F, Sönmez M. Ozdemir F, et al. J Exp Clin Cancer Res. 2004 Mar;23(1):93-5. J Exp Clin Cancer Res. 2004. PMID: 15149156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters